References
- Barbosa SL, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron P, Archambeaud-Mouveroux F, Conte-Devolx B, Rohmer V; Groupe d’Etude des Tumeurs Endocrines. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid 15, 618–623, 2005.10.1089/thy.2005.15.618
- Beuschlein F, Hammer GD. Ectopic pro-opiomelanocortin syndrome. Endocrinol Metab Clin North Am 31, 191–234, 2002.10.1016/S0889-8529(01)00025-1
- Burch JM, Choi JS, Mosalem O, Charles L. Ectopic ACTH production caused by metastatic parotid gland acinic cell carcinoma. AACE Clin Case Rep 7, 32–35, 2021.10.1016/j.aace.2020.11.006
- Butt MI, Rose DS, Robinson AM. Cushing syndrome secondary to ectopic acth secretion by dedifferentiated acinic cell carcinoma of the parotid gland. Endocrinologist 18, 161–162, 2008.10.1097/TEN.0b013e31817ffeb7
- Castro Oliveira S, Neves JS, Souteiro P, Belo S, Oliveira AI, Moreira H, Mergulhao Gomes P, Coelho L, Sarmento C, Fonseca E, Neves C, Freitas P, Carvalho D. Ectopic Cushing’s syndrome unveiling a metastatic parotid carcinoma. Case Rep Endocrinol 2019, 3196283, 2019.10.1155/2019/3196283
- Chapireau D, Adlam D, Cameron M, Thompson M. Paraneoplastic syndromes in patients with primary oral cancers: a systematic review. Br J Oral Maxillofac Surg 48, 338–344, 2010.10.1016/j.bjoms.2009.08.025
- Cox ML, Gourley RD, Kitabchi AE. Acinic cell adenocarcinoma of the parotid with ectopic production of adrenocorticotropic hormone. Am J Med 49, 529–533, 1970.10.1016/S0002-9343(70)80047-X
- Dacruz T, Kalhan A, Rashid M, Obuobie K. An Ectopic ACTH Secreting Metastatic Parotid Tumour. Case Rep Endocrinol 2016, 4852907, 2016.10.1155/2016/4852907474530626904316
- Fernandez PM, Brunel F, Jimenez MA, Saez JM, Cereghini S, Zakin MM. Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endocrinology 141, 2392–2400, 2000.10.1210/endo.141.7.756210875239
- Fukuoka H, Shichi H, Yamamoto M, Takahashi Y. The mechanisms underlying autonomous adrenocorticotropic hormone secretion in Cushing’s disease. Int J Mol Sci 21, 9132, 2020.10.3390/ijms21239132773015633266265
- Gomes CC, Diniz MG, Orsine LA, Duarte AP, Fonseca-Silva T, Conn BI, De Marco L, Pereira CM, Gomez RS. Assessment of TP53 mutations in benign and malignant salivary gland neoplasms. PLoS One 7, e41261, 2012.10.1371/journal.pone.0041261340057322829934
- Haller F, Bieg M, Will R, Körner C, Weichenhan D, Bott A, Ishaque N, Lutsik P, Moskalev EA, Mueller SK, Bähr M, Woerner A, Kaiser B, Scherl C, Haderlein M, Kleinheinz K, Fietkau R, Iro H, Eils R, Hartmann A, Plass C, Wiemann S, Agaimy A. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun 10, 368, 2019.10.1038/s41467-018-08069-x634110730664630
- Isidori AM, Kaltsas GA, Grossman AB. Ectopic ACTH syndrome. Front Horm Res 35, 143–156, 2006.10.1159/00009432316809930
- Jamieson L, Taylor SM, Smith A, Bullock MJ, Davis M. Metastatic acinic cell carcinoma of the parotid gland with ectopic ACTH syndrome. Otolaryngol Head Neck Surg 136, 149–150, 2007.10.1016/j.otohns.2006.04.00917210357
- Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T. Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol 5, 197–223, 2014.10.5306/wjco.v5.i3.197412759525114839
- Landon J, Ratcliffe JG, Rees LH, Scott AP. Tumour-associated hormonal products. J Clin Pathol Suppl 7, 127–134, 1974.10.1136/jcp.27.Suppl_7.127
- Lewis AG, Tong T, Maghami E. Diagnosis and management of malignant salivary gland tumors of the parotid gland. Otolaryngol Clin North Am 49, 343–380, 2016.10.1016/j.otc.2015.11.00127040585
- Lin VTG, Nabell LM, Spencer SA, Carroll WR, Harada S, Yang ES. First-line treatment of widely metastatic BRAF-mutated salivary duct carcinoma with combined BRAF and MEK inhibition. J Natl Compr Canc Netw 16, 1166–1170, 2018.10.6004/jnccn.2018.7056629244630323086
- Namboodiripad PCA. A review: Immunological markers for malignant salivary gland tumors. J Oral Biol Craniofac Res 4, 127–134, 2014.10.1016/j.jobcr.2014.05.003425264325737930
- Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 85, 838–854 2010.10.4065/mcp.2010.0099293161920810794
- Saluja K, Ravishankar S, Ferrarotto R, Zhu H, Pytynia KB, El-Naggar, AK. Ectopic ACTH production and Cushing’s syndrome in a patient with parotid acinic cell carcinoma with high-grade transformation: tumor context and clinical implications. Head Neck Pathol 14, 562–569, 2020.10.1007/s12105-019-01054-w723512831363907
- Shenoy VV, Lwin Z, Morton A, Hardy J. Ectopic adrenocorticotrophic hormone syndrome associated with poor prognosis in metastatic parotid acinic cell carcinoma. Otolaryngol Head Neck Surg 145, 878–879, 2011.10.1177/019459981140822421540317
- Teves DA. Clinical approach of Cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor. Endocrinologist 15, 401–404, 2005.10.1097/01.ten.0000188475.05398.09
- Wade L, Kitching P, De Winton E. Ectopic ACTH secretion secondary to metastatic acinic cell carcinoma of the parotid gland: A case report and review of current evidence for systemic therapy. J Investig Med High Impact Case Rep 8, 2324709620918080, 2020.10.1177/2324709620918080723204432410474